Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
about
Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma typesIsotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodiesThe usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient.Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.T cell-rich lymphoid infiltrates with large B cells: a review of key entities and diagnostic approach.EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report.Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma.Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.Neutrophil CD64 is upregulated in RA patients with lymphoma but not in other solid cancers.High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder.Iatrogenic lymphoproliferative disorder.Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders.Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis.Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.Composite Cutaneous Lymphoma (Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder) in a Patient with Rheumatoid Arthritis Treated with Methotrexate: Staging and Evaluation of Response to Therapy with 18F-FDG PET/CT.Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.Endobronchial Involvement in Methotrexate-associated Lymphoproliferative Disease.Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment.Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.18F-FDG PET-CT in a patient with methotrexate-associated lymphoproliferative disorder.Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis - A Case Report.Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case reportClassic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
P2860
Q33823265-B81EFC1E-56B4-4FA3-84AB-21D7C4FF9D2EQ35591973-9A9F3ACC-22AA-4CC7-8AE3-8A7321B3382EQ36104671-692131DE-4CBA-4024-B2A2-5A4A1A398541Q36131098-ACD0677C-20EA-47D9-98F5-48C88C79C624Q36615097-0526C926-9DE6-47C3-8E55-492BD4F0B4C3Q37398907-675FDFCE-7401-4447-A254-506ED4EDB1D4Q38652100-EE186302-649B-4244-B9FD-6CF6DD031697Q39022877-E87D51FB-932D-4433-A7D1-4C86B0172A5CQ39232131-44E4BFA3-FBA9-402E-868E-462C0CE44AE9Q39309064-8331FF70-0669-4B7F-9C75-FC1071039360Q39626822-975D77AC-AF90-4F32-BAC6-9BFAC8D5862AQ40055511-6DAF60B6-E393-4645-A4F5-2138A497D939Q40128985-EAC733A0-9960-4B6A-AFCB-94349BCFBA11Q40156397-BC721FF6-24FD-4920-99C0-8C98F499DCA6Q40444592-B6FB7E7A-8EB5-4076-AD6C-F383F29DF3A6Q40474665-E5C82692-2366-4153-81E5-D69057045EF5Q40956008-392F7E5D-D219-46B3-8F12-FDFF3257D0A2Q40993891-9802ED05-DD27-4428-86DE-D78F59624FCEQ41457465-E4239D9B-6156-4105-BECF-D75D3CA626DCQ41645710-ADDF52A8-A84B-4725-9F4F-AA4E19FAF7E7Q41706567-FB6C3E0C-AD8E-4198-B3DC-60A80265A5ECQ42181333-10D8FA62-FE58-45B7-8F06-24BC4411855AQ42224754-9BE4CC37-2552-47F7-9BEF-E09B97A2EF40Q42660665-7CEBEF66-90E6-44A3-8AB8-C50535008BD7Q47567474-FF02D4DE-5DE5-46D0-BCAF-D93E4FCDB7A9Q47570516-E7B2B6DE-0D7D-4A28-ADA0-B96A2A7BFF66Q47573030-6F094E55-E417-4325-8100-B1DEAFF1AD4FQ50066766-B018EAE7-D821-49EE-9825-2411085B0BE5Q50211353-5B6C1E73-3FBB-49D7-8344-9E375320BC7FQ51000616-B8191DE5-D61B-45FD-96D2-F375E17A4226Q51539739-29D2FCE9-C7A8-4B8D-B4BB-948AE42D2BA4Q52718405-C7702733-39D6-4501-9234-BCE1DFE67B8FQ52984093-68B60CE6-230D-4B53-B3B6-7067D08F0139Q53721205-9890D061-8746-456B-BD1C-4DBC5902F708Q55186230-E9AD04CD-8DD8-4F45-AA91-4EFB7D00ACFBQ55239074-33F81D7F-DF74-4543-92E4-715FC821FBE2Q57098973-D9650483-E7E4-43B8-A9E8-BAC69478DB84Q58766568-5984B508-0440-4848-83A6-F402A791D450
P2860
Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Methotrexate/iatrogenic lympho ...... se progression and regression.
@en
Methotrexate/iatrogenic lympho ...... se progression and regression.
@nl
type
label
Methotrexate/iatrogenic lympho ...... se progression and regression.
@en
Methotrexate/iatrogenic lympho ...... se progression and regression.
@nl
prefLabel
Methotrexate/iatrogenic lympho ...... se progression and regression.
@en
Methotrexate/iatrogenic lympho ...... se progression and regression.
@nl
P2093
P2860
P356
P1476
Methotrexate/iatrogenic lympho ...... se progression and regression.
@en
P2093
Ayako Ichikawa
Daisuke Niino
Fumiko Arakawa
Hiroaki Miyoshi
Junichi Kiyasu
Kensaku Sato
Koichi Ohshima
Maki Yoshida
Masanori Takeuchi
Osamu Miura
P2860
P356
10.1111/EJH.12116
P577
2013-05-13T00:00:00Z